Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jacqueline J. Glascock
Gene Therapy in Mouse Models of Spinal Muscular Atrophy :||Using SMN Gene Replacement to Address Biological Questions
Related publications
014 AVXS-101 Gene-Replacement Therapy (GRT) in Presymptomatic Spinal Muscular Atrophy (SMA): Study Update
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
P.065 AVXS-101 Gene-Replacement Therapy (GRT)) in Presymptomatic Spinal Muscular Atrophy (SMA): Study Update
Canadian Journal of Neurological Sciences
Medicine
Neurology
Psy16 - Health Outcome Improvements in Spinal Muscular Atrophy Type 1 Patients With Avxs-101 Gene Replacement Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy18 - Rapid Improvements in Motor Function in Spinal Muscular Atrophy Type 1 Following Avxs-101 Gene Replacement Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Muscle-Specific SMN Reduction Reveals Motor Neuron–independent Disease in Spinal Muscular Atrophy Models
Journal of Clinical Investigation
Medicine
SMN Blood Levels in a Porcine Model of Spinal Muscular Atrophy
Journal of Neuromuscular Diseases
Neurology
The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
Frontiers in Neurology
Neurology
Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
066 Avxs-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 1 (SMA1): Pivotal Phase 3 Study (STR1VE) Update
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery